Skip to main content

Female Hair Loss Causes vs Male Pattern Hair Loss

What causes hair loss in women and how does it differ from male pattern hair loss?

The single biggest mistake in women's hair loss is assuming there's one cause. In men, an inherited sensitivity to dihydrotestosterone explains most cases and you can usually spot it from across the room. In women that same sensitivity is often just one thread running alongside hormonal shifts, low iron stores, thyroid disease or a shed triggered by something that happened months ago, and untangling which threads are pulling is what decides whether your treatment works.

Criteria Women Men
Usual cause Several drivers stacked together Androgenetic, single dominant cause
Visible pattern Widening central part, hairline kept Temple recession plus crown thinning
Grading scale Ludwig or Sinclair Norwood
Workup before treatment History, pull test, trichoscopy, bloods Often inspection alone
Donor zone for surgery Frequently involved, needs assessment Usually stable and reliable
The Bottom Line

Female hair loss usually reflects several overlapping drivers rather than one, so a widening central part with a preserved hairline needs a full diagnostic workup before any treatment decision, while male pattern loss can typically be diagnosed by inspection.

What is female pattern hair loss and what happens at the follicle level?

Your follicles aren't dying here, they're shrinking. Each growth cycle a susceptible follicle turns out a slightly shorter, finer, paler hair, and the growth phase itself collapses from two to six years down to months. That distinction is the whole reason early treatment is worth anything: a miniaturised follicle is still alive and can be pushed back, while a scarred one is gone for good.

  • Cycle shift: Resting telogen follicles rise from ten to fifteen percent up past fifteen percent.
  • Unit thinning: Groupings that made three or four hairs drop to two, then one.
  • Diameter diversity: Variability above roughly twenty percent is the diagnostic signature under magnification.
  • Regional bias: Crown and mid scalp carry more androgen receptors and type 2 5-alpha reductase.
Critical Insight

Female pattern hair loss is follicular miniaturisation rather than follicle loss, with resting-phase follicles rising above fifteen percent and hair-shaft diameter varying by more than about twenty percent, and it stays reversible until the follicular opening scars over.

Which hormonal changes drive hair thinning in women?

Here's what trips people up: your bloodwork can come back completely normal and you can still have textbook pattern thinning. Circulating androgen levels in women are a fraction of male levels, so what matters is how sensitive your follicles are to what's already there, not how much of it you've got. A normal panel never rules the diagnosis out, it only tells you how hard to hunt for an endocrine cause underneath.

Perimenopause and menopause: Oestrogen and progesterone fall while androgens decline slower, so dormant thinning can accelerate visibly over two or three years.
Polycystic ovary syndrome: Genuinely raised androgens, sometimes showing on the scalp first, so unexplained thinning in your twenties or thirties earns questions about cycle regularity, insulin resistance and weight change.
Pregnancy and postpartum: High oestrogen holds follicles growing, then the deferred shed lands two to three months after delivery as a normal correction.
Contraceptive changes: A shed a few months after starting or stopping, with progestin formulations differing in how androgenic they are.
Key Fact

Female pattern thinning is usually driven by follicular receptor sensitivity rather than excess hormone, so normal levels of total and free testosterone, DHEA sulphate, sex hormone binding globulin and prolactin never exclude the diagnosis.

What non-hormonal triggers cause sudden or diffuse shedding in women?

When you suddenly find hair in the drain, the cause is almost never last week. Telogen effluvium runs on a delay, so the thing that knocked your follicles out of their growth phase happened two to three months earlier, which is exactly why the event people blame is usually innocent. Ask what was going on last season, not last Tuesday.

  1. The trigger: Childbirth, surgery or anaesthesia, high fever, severe infection, crisis, crash dieting, or drugs including retinoids, beta blockers, anticonvulsants and high dose vitamin A.
  2. The lag: Roughly two to three months of nothing before shedding starts.
  3. The shed: Full length hairs with a pale bulb and uniform shaft thickness, running at several times the normal fifty to a hundred a day.
  4. The peak: Within a couple of months of the shed starting.
  5. The recovery: Six to nine months to resolve once the trigger's gone, with a fringe of short regrowth along the hairline first.
The Lay of the Land

Acute telogen effluvium begins two to three months after its trigger and resolves within six to nine months of that trigger being removed, while chronic telogen effluvium lasts beyond six months, fluctuates, and thins the sides as well as the part line.

How do nutritional deficiencies and thyroid disease contribute to thinning?

Two lab results account for a big share of the thinning that's actually fixable, and both get missed because the reference ranges weren't built with your hair in mind. You can be told your iron is fine because you're not anaemic while your ferritin sits at fifteen. Below that top tier, the evidence gets thin fast and the supplement aisle gets loud.

Tier 1, the two that carry most of the correctable cases: Ferritin and thyroid function, both tested properly rather than superficially.
Ferritin near forty to seventy micrograms per litre is what most hair specialists want before judging a response, and thyroid stimulating hormone alone often isn't enough without free T4 and antibodies.
Tier 2, worth measuring when your history gives a reason: Vitamin D, zinc and B12.
Supplementing a level that's already normal does nothing at all.
Tier 3, where the marketing outruns the evidence: Biotin, plus overlapping multi-ingredient hair supplements.
Genuine biotin deficiency is rare, and supplementing it skews thyroid and cardiac lab assays while excess vitamin A or selenium actually causes shedding.
Worth Knowing

Ferritin below roughly forty to seventy micrograms per litre and untreated thyroid disease account for a large share of correctable thinning in women, and once either is corrected it takes three months before anything changes and six to twelve months before density improves.

How does the pattern and distribution of loss differ between women and men?

Geometry is where these two conditions separate most obviously. Men lose ground at the temples and the crown until the two meet, leaving that horseshoe of permanent hair. Women usually keep a frontal fringe of one to three centimetres and thin behind it, so what you notice first is a part that widens like a road seen from above, a thinner ponytail, or more scalp under the bathroom light, well before anyone else spots it.

Criteria Female pattern Male pattern
Starting point Central part, behind a kept fringe Temples and crown, independently
Frontal hairline Preserved, one to three centimetres Recedes at the corners
Grading Ludwig in three stages, Sinclair in five Norwood, front and crown advancing together
Refinement Olsen or Christmas tree taper towards crown Horseshoe of permanent hair remains
Back and sides Often mildly involved Reliably resistant, useful as donor
Decision Point

Women typically retain a frontal fringe of one to three centimetres and thin outward from the central part, so true temporal recession in a woman points instead towards significant androgen excess or frontal fibrosing alopecia and warrants urgent assessment.

Why do the underlying mechanisms differ between female and male pattern loss?

The name changed from female androgenetic alopecia to female pattern hair loss for a reason, and that reason is honest uncertainty. In men the chain is settled: inherited receptor sensitivity plus dihydrotestosterone equals miniaturisation, and blocking the conversion slows it reliably. In women that chain clearly runs in some cases and clearly doesn't in others, which is why hormone blockade gives you a far more variable response.

  • Aromatase levels: Female frontal scalp carries substantially more, diverting testosterone towards oestradiol.
  • Reductase levels: Lower type 1 and type 2 5-alpha reductase than male scalp in the same region.
  • Inheritance: X-chromosome androgen receptor variants explain far less, so family history predicts weakly.
  • Inflammation: Microinflammation and perifollicular fibrosis show on biopsy in a meaningful share of women.
The Deciding Factor

The female frontal scalp carries substantially more aromatase and less type 1 and type 2 5-alpha reductase than male scalp, so female pattern loss is a common final appearance produced by several modest contributing processes at once rather than one dominant hormonal chain.

Which scarring and inflammatory conditions are mistaken for ordinary female thinning?

This is the part where waiting costs you permanently. Scarring alopecia destroys the follicle outright, so every month it gets treated as ordinary thinning is a month you don't get back. If your scalp looks shiny and smooth with no visible openings, if there's redness or scale around individual hairs, if it itches, burns or feels tender, or if the edge of the loss is sharp rather than fading gradually, that's your cue to stop the routine assessment.

Hairline moving back in a band, with eyebrow loss: Suspect frontal fibrosing alopecia, especially after menopause, with pale scarred skin behind the new hairline and stranded single hairs in the bare zone.
Loss starting at the crown and spreading outwards, often tender first: Suspect central centrifugal cicatricial alopecia, disproportionately affecting women of African descent.
Patchy loss with scale collared around the shafts: Suspect lichen planopilaris, which ends in the same permanently scarred outcome.
Loss at the margins after years of tight braids, weaves or ponytails: Traction alopecia, with a retained fringe of fine hairs at the very edge as the classic clue, and entirely preventable.
Authority Warning

A four millimetre punch biopsy taken from an active edge rather than a bald centre confirms scarring alopecia, and any rapidly changing, symptomatic or oddly shaped pattern of loss calls for urgency rather than watchful waiting because scarred follicles never regrow.

What does a proper diagnostic workup for a woman with hair loss involve, and how does it differ from a man's?

The gap in effort is the whole story. A man with a receding hairline, a thinning crown and a family history gets a confident diagnosis by inspection in a few minutes. You could have any of six overlapping conditions behind that widening part, so your assessment has to be genuinely investigative rather than a glance.

  1. Timeline: When it started, abrupt or gradual, what was happening three to six months before, pregnancies, cycles, menopausal status, weight change, dieting, every medication and supplement with start dates, styling history, family history.
  2. Examination: Scalp parted in several places to compare the part against the occipital scalp, plus inspection of follicular openings for scarring signs.
  3. Pull test: About fifty to sixty hairs drawn along their length, with more than roughly six coming away suggesting active shedding.
  4. Trichoscopy: Diameter diversity and fewer hairs per unit means pattern loss, uniform calibre with empty openings means a shed, absent openings with perifollicular scale means scarring.
  5. Bloods and photographs: Ferritin with iron studies, thyroid stimulating hormone with free T4, vitamin D, zinc and a full blood count every time, adding the androgen panel where excess is suspected, alongside standardised photos for three to six month comparison.
In Practice

A woman's workup routinely includes ferritin with full iron studies, thyroid stimulating hormone with free T4, vitamin D, zinc and a full blood count, plus a pull test where more than about six of fifty to sixty hairs coming away indicates active shedding, a panel and examination a man would not routinely need.

How does the difference in cause change which treatments actually work?

Sequence beats product choice every time. Start a topical while low ferritin, an off thyroid, a crash diet or a medication is still driving the shed, and you'll get a disappointing result that then gets blamed on the topical. Clear the field first, then judge what you put on top of it.

First, correct the drivers: Ferritin, thyroid function, ongoing dieting, and any medication pushing a shed.
Nothing layered on top gets a fair trial until these are handled.
Second, the mainstay: Topical minoxidil, the one option with regulatory approval specifically for women, with two percent twice daily and five percent once daily performing comparably.
Expect an initial shed at four to eight weeks, visible change at four months at the earliest, a fair verdict only at twelve months.
Third, the hormonal options, where the male playbook stops: Oral 5-alpha reductase inhibitors off label with reliable contraception and most comfortably after menopause, antiandrogens such as spironolactone off label with potassium monitoring.
Both are teratogenic risks, so pregnancy precautions are strict rather than advisory.
Fourth, adjunctive and surgical: Low level laser devices with modest evidence, injectable platelet rich plasma as supportive rather than foundational, and surgery only where the donor zone is genuinely stable.
Diffuse involvement disqualifies a larger proportion of women than men from surgical restoration.
Pro Tip

None of these treatments is curative, and hair that depends on treatment sheds again within about four to six months of stopping, so correcting ferritin, thyroid and medication drivers before starting topical minoxidil is what separates a durable plan from one abandoned in disappointment.

Daniel Zengel
Written by Daniel Zengel
Medical Writer
Daniel Zengel is the principal owner of H-SHOT and a medical writer covering platelet-rich plasma and hair restoration. He draws on more than a decade in pharmaceutical and medical device roles, with a focus on regenerative medicine and the device standards and provider training that make PRP results consistent from clinic to clinic.